Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
15 Sep 2020
Historique:
received: 18 11 2019
revised: 11 06 2020
accepted: 16 07 2020
pubmed: 25 7 2020
medline: 19 5 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Alamandine attenuates hypertension and cardiac remodeling in spontaneously hypertensive rats (SHRs). We examined whether alamandine attenuates vascular remodeling in mice, and regulates angiotensin II (Ang II)-induced fibrosis in rat vascular smooth muscle cells (VSMCs). Alamandine attenuated hypertension in mice induced by Ang II. Ang II increased the fibrosis of thoracic aorta in mice, which was attenuated by alamandine treatment. Increased levels of collagen I, transforming growth factor-β (TGF-β), and connective tissue growth factor (CTGF) levels in thoracic aortas after Ang II treatment in mice were inhibited by alamandine. Ang II-stimulated collagen I, TGF-β, and CTGF level increases were inhibited by alamandine in rat VSMCs. This could be reversed by Mas-related G protein-coupled receptor, member D (MrgD) antagonist D-Pro

Identifiants

pubmed: 32707188
pii: S0014-2999(20)30476-3
doi: 10.1016/j.ejphar.2020.173384
pii:
doi:

Substances chimiques

Antihypertensive Agents 0
Mrgprd protein, mouse 0
Mrgprd protein, rat 0
Nerve Tissue Proteins 0
Oligopeptides 0
Receptors, G-Protein-Coupled 0
alamandine 0
Angiotensin II 11128-99-7
p38 Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

173384

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Chuanxi Yang (C)

Medical Department of Southeast University, Nanjing, China.

Xiaoguang Wu (X)

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Yihui Shen (Y)

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Chi Liu (C)

Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

Xiangqing Kong (X)

Medical Department of Southeast University, Nanjing, China; Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: kongxq@njmu.edu.cn.

Peng Li (P)

Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: lipeng198610@163.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH